Diagnosis and Treatment of Polycystic Ovary Syndrome

Polycystic ovary syndrome is the common endocrinopathy among reproductive-aged females in the all over the world, affecting approximately 6% of female patients. The pathophysiology of the disease is complex and there is no single defect from which it is known to result, it is hypothesized that insulin resistance is a key factors from asymptomatic to having multiple gynecologic, dermatologic, or metabolic manifestations. Advices from the Endocrine Society mentioned using the Rotterdam criteria for diagnosis, which mandate the presence of two of the following three findings—hyperandrogenism, ovulatory dysfunction, and polycystic ovaries and plus the exclusion of other diagnoses that could result in ovulatory dysfunction.

 

    Related Conference of Diagnosis and Treatment of Polycystic Ovary Syndrome

    March 18-19,2020

    World congress on Women Health and  Reproductive Medicine

    Auckland, New Zealand
    March 24-25, 2020

    International Meeting on Reproductive Medicine and Womens Health

    Amsterdam | Netherlands
    April 24-25, 2020

    Obstetrics Gynecology 2020

    Geneva, Switzerland

    Diagnosis and Treatment of Polycystic Ovary Syndrome Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in